In wake of Avandia scandal, drugmaker pitches Actos as safe

In a clear response to the recent "black box" label designation for Avandia, the makers of another drug commonly used to treat Type 2 diabetes have begun a large advertising campaign promoting the drug's safety. Takeda Pharmaceutical Co., which makes popular diabetes drug Actos, is now running full-page advertisements in newspapers noting that the drug lowers blood sugar "without increasing your risk of having a heart attack or stroke."

As such things go, Takeda has actually shown some restraint, as Avandia has been under serious fire for quite some time. Questions over Avandia's safety have been surfacing for years, but it took the biggest hit earlier this year, when a journal article claimed that it pushed up the risk of heart attack in diabetics by 43 percent.

To learn more about the campaign:
- read this Medical News Today article

Related Articles:
Avandia gets black-box warning. Report
VA removes Avandia from its formulary. Report
Avandia controversy sparks FDA criticism. Report
Glaxo: Avandia's safe as other diabetes drugs. Report
Avandia critic: FDA launched smear campaign. Report
Diabetes expert issued harsh Avandia critique in 2000. Report

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.